tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

AU:ATX Stock Latest News

Amplia Therapeutics Completes Early Recruitment for Promising Pancreatic Cancer Trial
Company AnnouncementsAmplia Therapeutics Completes Early Recruitment for Promising Pancreatic Cancer Trial
22h ago
Amplia Therapeutics Advances Cancer Treatment with Promising Trial Results and Strategic Collaborations
PremiumCompany Announcements
Amplia Therapeutics Advances Cancer Treatment with Promising Trial Results and Strategic Collaborations
2d ago
Amplia Therapeutics Unveils Promising Data for Narmafotinib at Keystone Meeting
PremiumCompany Announcements
Amplia Therapeutics Unveils Promising Data for Narmafotinib at Keystone Meeting
12d ago
Amplia Therapeutics Secures $13 Million in Capital Raise
PremiumCompany Announcements
Amplia Therapeutics Secures $13 Million in Capital Raise
1M ago
Amplia Therapeutics Announces Director’s Increased Shareholding
PremiumCompany Announcements
Amplia Therapeutics Announces Director’s Increased Shareholding
1M ago
Amplia Therapeutics Announces Director’s Share Acquisition
PremiumCompany AnnouncementsAmplia Therapeutics Announces Director’s Share Acquisition
1M ago
Amplia Therapeutics Announces Change in Director’s Interest
Premium
Company Announcements
Amplia Therapeutics Announces Change in Director’s Interest
1M ago
Amplia Therapeutics Director Increases Stake, Boosting Investor Interest
Premium
Company Announcements
Amplia Therapeutics Director Increases Stake, Boosting Investor Interest
1M ago
Amplia Therapeutics Lists New Securities on ASX
PremiumCompany Announcements
Amplia Therapeutics Lists New Securities on ASX
1M ago
Amplia Therapeutics Issues New Equity Options
PremiumCompany Announcements
Amplia Therapeutics Issues New Equity Options
1M ago
Amplia Therapeutics Shows Promising Data in Cancer Trial
PremiumCompany Announcements
Amplia Therapeutics Shows Promising Data in Cancer Trial
2M ago
Acorn Capital Increases Stake in Amplia Therapeutics
PremiumCompany Announcements
Acorn Capital Increases Stake in Amplia Therapeutics
2M ago
Amplia Therapeutics Reports Increased Losses Amid Revenue Decline
PremiumCompany AnnouncementsAmplia Therapeutics Reports Increased Losses Amid Revenue Decline
2M ago
Amplia Therapeutics Completes Successful Fundraising Effort
Premium
Company Announcements
Amplia Therapeutics Completes Successful Fundraising Effort
2M ago
Amplia Therapeutics Sets EGM for Shareholder Approvals
Premium
Company Announcements
Amplia Therapeutics Sets EGM for Shareholder Approvals
2M ago
Amplia Therapeutics Partners with Next&Bio for Cancer Research
PremiumCompany Announcements
Amplia Therapeutics Partners with Next&Bio for Cancer Research
3M ago
Amplia Therapeutics Shareholding Update by Platinum Asset
PremiumCompany Announcements
Amplia Therapeutics Shareholding Update by Platinum Asset
3M ago
Amplia Therapeutics Completes $13M Share Allotment
PremiumCompany Announcements
Amplia Therapeutics Completes $13M Share Allotment
3M ago
Amplia Therapeutics Lists New Shares on ASX
PremiumCompany Announcements
Amplia Therapeutics Lists New Shares on ASX
3M ago
Amplia Therapeutics to Issue New Securities on ASX
PremiumCompany AnnouncementsAmplia Therapeutics to Issue New Securities on ASX
3M ago
Amplia Therapeutics Boosts Stock Confidence with Underwritten Offer
Premium
Company Announcements
Amplia Therapeutics Boosts Stock Confidence with Underwritten Offer
3M ago
Amplia Therapeutics Announces $4.9M Capital Raising Plan
Premium
Company Announcements
Amplia Therapeutics Announces $4.9M Capital Raising Plan
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >